Bioequivalence Study to Compare Chenodeoxycholic Acid Capsules (250mg Chenodeoxycholic Acid) Versus Chenodeoxycholic Acid Leadiant 250 mg Hard Capsules (250mg Chenodeoxycholic Acid)

NCT06180057 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Cerebrotendinous Xanthomatoses

Interventions

DRUG: Chenodeoxycholic acid
DRUG: Chenodeoxycholic acid leadiant

Sponsor

Humanis Saglık Anonim Sirketi